Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Genomics and type I diabetes].

C Julier1

  • 1Laboratoire de Génétique de la Prédisposition aux Maladies Infectieuses, Institut Pasteur, 28 rue du Docteur Roux-75724 Paris.

Bulletin De L'Academie Nationale De Medecine
|March 23, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SLC29A3 mutation in a patient with syndromic diabetes with features of pigmented hypertrichotic dermatosis with insulin-dependent diabetes, H syndrome and Faisalabad histiocytosis.

Diabetes & metabolism·2013
Same author

Confirmation of novel type 1 diabetes risk loci in families.

Diabetologia·2012
Same author

Overview of the Type I Diabetes Genetics Consortium.

Genes and immunity·2009
Same author

Current status and the future for the genetics of type I diabetes.

Genes and immunity·2009
Same author

rs2476601 T allele (R620W) defines high-risk PTPN22 type I diabetes-associated haplotypes with preliminary evidence for an additional protective haplotype.

Genes and immunity·2009
Same author

Association analysis of SNPs in the IL4R locus with type I diabetes.

Genes and immunity·2009
Same journal

[Advances and perspectives in vascularized composite allotransplantation preservation].

Bulletin de l'Academie nationale de medecine·2025
Same journal

[COVID-19: Neurological manifestations and complications during the acute phase of the disease].

Bulletin de l'Academie nationale de medecine·2024
Same journal

[Role of psychological factors in post-COVID-19 condition].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[From the origin of Sars-CoV-2 to dangerous virology/biology].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Neurological forms of long COVID in adults: Critical approach].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Post-COVID-19 syndrome].

Bulletin de l'Academie nationale de medecine·2023
See all related articles

Genome-wide studies identified two major genetic factors for Type I diabetes: the HLA locus and the insulin gene. Research continues to uncover additional genes and environmental interactions influencing disease susceptibility.

Area of Science:

  • Genetics and Genomics
  • Immunology
  • Endocrinology

Context:

  • Type I diabetes (T1D) is a complex autoimmune disease with a significant genetic component.
  • Genome-wide association studies (GWAS) are crucial for identifying genetic risk factors in T1D.
  • Previous research has identified the HLA locus and insulin gene as key T1D susceptibility loci.

Purpose:

  • To review the current understanding of genetic factors contributing to Type I diabetes.
  • To highlight the challenges in identifying all T1D susceptibility genes due to polygenicity and gene-environment interactions.
  • To emphasize the need for integrated genetic and biological approaches to elucidate T1D pathogenesis.

Summary:

  • Genome-wide studies have identified two primary genetic determinants for Type I diabetes: the Human Leukocyte Antigen (HLA) locus and the insulin gene.

Related Experiment Videos

  • Identifying additional T1D susceptibility genes is challenging due to their large number, complex interactions (gene-gene and gene-environment), and potentially small, heterogeneous effects across populations.
  • Advancements in human genome knowledge and technology are expected to accelerate the discovery and functional characterization of T1D-associated genes.

    • Impact:

    • Improved understanding of T1D genetic architecture can lead to more accurate risk prediction.
    • Elucidation of gene functions may reveal novel therapeutic targets for Type I diabetes.
    • This research underpins personalized medicine approaches for T1D prevention and treatment.